United States · FDA National Drug Code directory
BUPRENORPHINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-1154_7849a4c0-f2ad-4a5b-bc72-be1b477e9ce4
- Product NDC
- 71335-1154
- Form
- TABLET
- Composition / generic term
- BUPRENORPHINE
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20171025
- Source listing expiry
- 20271231
Source-listed ingredients
- BUPRENORPHINE HYDROCHLORIDE — 8 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 120 TABLET in 1 BOTTLE (71335-1154-0) · 71335-1154-0
- 90 TABLET in 1 BOTTLE (71335-1154-1) · 71335-1154-1
- 60 TABLET in 1 BOTTLE (71335-1154-2) · 71335-1154-2
- 30 TABLET in 1 BOTTLE (71335-1154-3) · 71335-1154-3
- 20 TABLET in 1 BOTTLE (71335-1154-4) · 71335-1154-4
- 7 TABLET in 1 BOTTLE (71335-1154-5) · 71335-1154-5
- 28 TABLET in 1 BOTTLE (71335-1154-6) · 71335-1154-6
- 1 TABLET in 1 BOTTLE (71335-1154-7) · 71335-1154-7
- 12 TABLET in 1 BOTTLE (71335-1154-8) · 71335-1154-8
- 14 TABLET in 1 BOTTLE (71335-1154-9) · 71335-1154-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →